Correction
After the publication of this work [1], we noticed that we had incorrectly used the term ‘OGX-011’. All instances of OGX-011 in the manuscript should be changed to ‘ASO-CLU’.
We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.
Contributor Information
Qingfeng Chen, Email: chenqf.sdqd@yahoo.com.
Zhengkun Wang, Email: wangzhengkun@yahoo.com.cn.
Kejun Zhang, Email: wlsdermyy@163.com.
Xiaoyi Liu, Email: liuxiaoyi6@163.com.
Weihong Cao, Email: gail200279@yahoo.com.cn.
Lei Zhang, Email: leizhang@sohu.com.
Shuhua Zhang, Email: comzsh1983well@163.com.
Bomin Yan, Email: Yanbomin818@yahoo.com.cn.
Yaoguang Wang, Email: chenqf628@163.com.
Chunping Xia, Email: zsh1983well@163.com.
References
- Chen. et al. Clusterin confers gmcitabine resistance in pancreatic cancer. World J Surg Oncol. 2011;11:59. doi: 10.1186/1477-7819-9-59. [DOI] [PMC free article] [PubMed] [Google Scholar]